Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.45 |
| ▸ | LARS1 | Q9P2J5 | 3/20 | 0.40 |
| ▸ | SCN9A | Q15858 | 4/20 | 0.39 |
| ▸ | ANPEP | P15144 | 3/20 | 0.39 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.39 |
| ▸ | DNPEP | Q9ULA0 | 2/20 | 0.39 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.36 |
| ▸ | CTSC | P53634 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29010766 | 1.00 | SLC7A5 (0.45) | SLC7A5LARS1SCN9AANPEPRNPEP | |
| SCHEMBL21625553 | 1.00 | SLC7A5 (0.45) | SLC7A5LARS1SCN9AANPEPRNPEP | |
| SCHEMBL29010817 | 1.00 | SLC7A5 (0.45) | SLC7A5LARS1SCN9AANPEPRNPEP | |
| SCHEMBL7318989 | 1.00 | SLC7A5 (0.45) | SLC7A5LARS1SCN9AANPEPRNPEP | |
| SCHEMBL8863575 | 0.93 | SLC7A5 (0.40) | SLC7A5LARS1SCN9AANPEPRNPEP | |
| SCHEMBL1795666 | 0.93 | SLC7A5 (0.40) | SLC7A5LARS1SCN9AANPEPRNPEP | |
| SCHEMBL28082201 | 0.92 | MMP2 (0.39) | SLC7A5LARS1SCN9AANPEPRNPEP | |
| SCHEMBL2184616 | 0.92 | MMP2 (0.39) | SLC7A5LARS1SCN9AANPEPRNPEP | |
| SCHEMBL3498456 | 0.90 | SLC7A5 (0.40) | SLC7A5LARS1SCN9ASLC1A3SLC1A2 | |
| SCHEMBL6141906 | 0.90 | DPP4 (0.36) | SLC7A5LARS1SCN9AANPEPRNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230381267-A1 | OXYTOCIN TREATMENT FOR HYPERMOBILE EHLERS-DANLOS SYNDROME | BAYLOR COLLEGE OF MEDICINE | 2023-11-30 | — | — | US | claimed |
| EP-4221834-A1 | OXYTOCIN TREATMENT FOR HYPERMOBILE EHLERS-DANLOS SYNDROME | Baylor College of Medicine (US) | 2023-08-09 | — | — | EP | claimed |
| CN-1658819-A | Care and/or make-up cosmetic composition structured with silicone polymers and organogelling agents, in rigid form | OREAL (FR) | 2005-08-24 | — | — | CN | claimed |
| EP-1515684-A2 | CARE AND/OR MAKE-UP COSMETIC COMPOSITION STRUCTURED WITH SILICONE POLYMERS AND ORGANOGELLING AGENTS, IN RIGID FORM | L'OREAL (FR) | 2005-03-23 | — | — | EP | claimed |
| WO-2003105788-A2 | CARE AND/OR MAKE-UP COSMETIC COMPOSITION STRUCTURED WITH SILICONE POLYMERS AND ORGANOGELLING AGENTS, IN RIGID FORM | L'OREAL (FR) | 2003-12-24 | — | — | WO | claimed |
| US-6468977-B1 | COMPOUNDS USEFUL IN TREATMENT TREATMENT OF DISORDER AND/OR DISEASE CAUSED BY ACTIVITY OF ENZYMES SUCH AS HUMAN RHINOVIRUS 3C PROTEASE, TRANSGLUTAMINASE AND CATHEPSINS | APOTEX INC. (CA) | 2002-10-22 | — | — | US | claimed |
| EP-0272671-B1 | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors | SANDOZ LTD (CH) | 1994-03-16 | — | — | EP | claimed |
| US-5055451-A | Prevent tissue damage | SYNTEX INC. (US) | 1991-10-08 | — | — | US | claimed |
| EP-0272671-A2 | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors | SANDOZ LTD. (CH) | 1988-06-29 | — | — | EP | claimed |
| US-20230381267-A1 | OXYTOCIN TREATMENT FOR HYPERMOBILE EHLERS-DANLOS SYNDROME | BAYLOR COLLEGE OF MEDICINE | 2023-11-30 | — | — | US | disclosed |
| EP-4221834-A1 | OXYTOCIN TREATMENT FOR HYPERMOBILE EHLERS-DANLOS SYNDROME | Baylor College of Medicine (US) | 2023-08-09 | — | — | EP | disclosed |
| CN-109879933-B | Phosphoryl-containing compound and application thereof | 河北科技大学 | 2023-06-06 | — | — | CN | disclosed |
| CN-109796519-B | Steroid compound and application thereof | 河北科技大学 | 2023-01-10 | — | — | CN | disclosed |
| WO-2021030267-A1 | COMPOSITIONS AND METHODS FOR INCREASED PROTEIN PRODUCTION IN BACILLUS LICHENIFORMIS | DANISCO US INC (US) | 2021-02-18 | — | — | WO | disclosed |
| US-5158936-A | Treating or prevention of tissue damage, inflammation, bone resporpption and muscular dystrophy | SYNTEX (U.S.A.) INC. (US) | 1992-10-27 | — | — | US | disclosed |
| US-5055451-A | Prevent tissue damage | SYNTEX INC. (US) | 1991-10-08 | — | — | US | disclosed |
| EP-0272671-A2 | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors | SANDOZ LTD. (CH) | 1988-06-29 | — | — | EP | disclosed |
| EP-0010297-B1 | DERIVATIVES OF POLYENE MACROLIDE ANTIBIOTICS CONTAINING AN AMINO SUGAR MOIETY, PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SCHERING CORPORATION (US) | 1983-04-13 | — | — | EP | disclosed |
| US-4272525-A | FUNGICIDES | SCHERING CORPORATION (US) | 1981-06-09 | — | — | US | disclosed |
| EP-0010297-A1 | Derivatives of polyene macrolide antibiotics containing an amino sugar moiety, process for the preparation thereof, and pharmaceutical compositions containing them | SCHERING CORPORATION (US) | 1980-04-30 | — | — | EP | disclosed |